ECSP003633A - PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE PHARMACEUTICAL SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A HYDRO-SOLUBILITY <100 MG / ML, AND PROCEDURE FOR - Google Patents

PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE PHARMACEUTICAL SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A HYDRO-SOLUBILITY <100 MG / ML, AND PROCEDURE FOR

Info

Publication number
ECSP003633A
ECSP003633A ECSP003633A ECSP003633A EC SP003633 A ECSP003633 A EC SP003633A EC SP003633 A ECSP003633 A EC SP003633A EC SP003633 A ECSP003633 A EC SP003633A
Authority
EC
Ecuador
Prior art keywords
partially
situ
solubility
hydro
procedure
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Iris Ziegler
Johannes Heinrich Antonius Bartholomaus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003633 priority Critical patent/ECSP003633A/en
Publication of ECSP003633A publication Critical patent/ECSP003633A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención se refiere a formas farmacéuticas oral al menos particularmente retardadas cuya sustancia activa farmacéutica tramadol se encuentra al menos parcialmente en forma de compuesto formado in situ con una hidrosolubilidad <= 100mg/ml, y procedimiento para su preparación.The invention relates to at least particularly delayed oral dosage forms whose pharmaceutical active ingredient tramadol is at least partially in the form of a compound formed in situ with a water solubility <= 100mg / ml, and method for their preparation.

ECSP003633 2000-08-24 2000-08-24 PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE PHARMACEUTICAL SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A HYDRO-SOLUBILITY <100 MG / ML, AND PROCEDURE FOR ECSP003633A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003633 ECSP003633A (en) 2000-08-24 2000-08-24 PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE PHARMACEUTICAL SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A HYDRO-SOLUBILITY <100 MG / ML, AND PROCEDURE FOR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003633 ECSP003633A (en) 2000-08-24 2000-08-24 PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE PHARMACEUTICAL SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A HYDRO-SOLUBILITY <100 MG / ML, AND PROCEDURE FOR

Publications (1)

Publication Number Publication Date
ECSP003633A true ECSP003633A (en) 2000-12-19

Family

ID=42041237

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003633 ECSP003633A (en) 2000-08-24 2000-08-24 PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE PHARMACEUTICAL SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A HYDRO-SOLUBILITY <100 MG / ML, AND PROCEDURE FOR

Country Status (1)

Country Link
EC (1) ECSP003633A (en)

Similar Documents

Publication Publication Date Title
AR025427A1 (en) PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN FORM OF A DEPOSIT FORMED IN SITU WITH A HYDROSOLUBILITY &lt;O = 100 MG / ML, AND PROCEDURE FOR PREPARATION
HUP0103000A2 (en) Bioenhanced formulations comprising eprosartan in oral solid dosage form and process for their preparation
IT1276689B1 (en) SOLID PHARMACEUTICAL FORM FOR ORAL USE
EA200000246A1 (en) QUICKLY DISINTEGRATING METAL CELLULOSE TABLETS
AR037490A1 (en) SOLID PHARMACEUTICAL COMPOSITIONS, PROCESS FOR PREPARATION, KIT FOR THE TREATMENT OF OBESITY AND USE OF SUCH COMPOSITIONS IN THE DEVELOPMENT OF MEDICINES
CA2301378A1 (en) Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
RS50876B (en) Use of flibanserin in the treatment of sexual disorders
EA200000245A1 (en) QUICKLY DISINTEGRATING METAL CELLULOSE TABLETS
CO5011053A1 (en) PROCEDURE FOR THE PRODUCTION OF A SOLID DOSAGE FORM CONTAINING CARVEDILOL AND HYDROCLOROTIAZIDA AND PHARMACEUTICAL FORMS OBTAINED BY SUCH PROCEDURE
WO2007009806A3 (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption
ATE541562T1 (en) IBUPROFEN SUSPENSION
EA200000487A1 (en) COMPOSITION OF PROLONGED SHIPPING
ECSP034826A (en) METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE
BR0111868A (en) Pharmaceutical Compositions
ES2191987T3 (en) DOSAGE FORMS OF RIBAVIRINA SOLIDAS, ADMINISTRABLE ORALALLY, AND MANUFACTURING PROCEDURE.
RU2003100507A (en) PHARMACEUTICAL COMPOSITIONS
NO20023551D0 (en) Ibuprofen-containing active agent preparation
DE60102590T2 (en) PHARMACEUTICAL FORMS FOR THE TREATMENT OF ORAL MYCOSES
AR036085A1 (en) DOSAGE FORMS AND PROCEDURE FOR MANUFACTURING
HUP0500842A2 (en) Pharmaceutical dronedarone composition for parenteral administration
WO2001080619A3 (en) Pharmaceutical composition containing citalopram
WO2004071156A3 (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
ECSP003633A (en) PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE PHARMACEUTICAL SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A HYDRO-SOLUBILITY &lt;100 MG / ML, AND PROCEDURE FOR
WO2003061557A3 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
UY26319A1 (en) PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE SUBSTANCE PHARMACEUTICAL TRAMADOL, IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A # 100 MG / ML WATER-SOLUBILITY AND PROCEDURE